6M
WST icon

6 Meridian’s West Pharmaceutical WST Stock Holding History

6 Meridian’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-701
Closed -$252K – 510
2021
Q2 		$252K Sell
701
-21
-3% -$6.94K 0.02% 257
2021
Q1 		$203K Buy
+722
New +$207K 0.02% 381
2020
Q3 		– Sell
-1,450
Closed -$329K – 397
2020
Q2 		$329K Sell
1,450
-2,457
-63% -$483K 0.03% 196
2020
Q1 		$595K Buy
+3,907
New +$601K 0.06% 179

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

6 Meridian's WST Position: Q3 2021 in Review

6 Meridian sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 701 shares — an estimated $252K sold.

6 Meridian first reported a position in WST in Q1 2020 and held it in 4 quarters. The position peaked at $595K in Q1 2020. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • 6 Meridian reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • 6 Meridian sold 701 West Pharmaceutical shares in Q3 2021, an estimated $252K.
  • 6 Meridian first reported a position in West Pharmaceutical in Q1 2020 and held it in 4 quarters.
  • 6 Meridian's West Pharmaceutical position peaked at $595K in Q1 2020.
  • 670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.